CN113121353B - Ferulic acid dimer with antioxidant activity and preparation method and application thereof - Google Patents
Ferulic acid dimer with antioxidant activity and preparation method and application thereof Download PDFInfo
- Publication number
- CN113121353B CN113121353B CN202110250452.5A CN202110250452A CN113121353B CN 113121353 B CN113121353 B CN 113121353B CN 202110250452 A CN202110250452 A CN 202110250452A CN 113121353 B CN113121353 B CN 113121353B
- Authority
- CN
- China
- Prior art keywords
- hydroxy
- methoxy
- methoxycarbonyl
- methoxyphenyl
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical class COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 title claims abstract description 14
- 230000003078 antioxidant effect Effects 0.000 title abstract description 21
- PXFAERRRGPZALQ-UHFFFAOYSA-N 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-methoxycarbonyl-3,4-dihydronaphthalene-2-carboxylic acid Chemical compound C12=CC(O)=C(OC)C=C2C=C(C(O)=O)C(C(=O)OC)C1C1=CC=C(O)C(OC)=C1 PXFAERRRGPZALQ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 23
- 235000009566 rice Nutrition 0.000 claims abstract description 20
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- -1 Ferulic acid dimer compound Chemical class 0.000 claims abstract description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- 241000209094 Oryza Species 0.000 claims description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000010898 silica gel chromatography Methods 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 2
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 2
- 238000004128 high performance liquid chromatography Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 23
- 239000003963 antioxidant agent Substances 0.000 abstract description 12
- 239000003814 drug Substances 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 11
- 240000007594 Oryza sativa Species 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 4
- UOBYKYZJUGYBDK-UHFFFAOYSA-N 2-naphthoic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CC=C21 UOBYKYZJUGYBDK-UHFFFAOYSA-N 0.000 abstract description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract description 2
- 238000000338 in vitro Methods 0.000 abstract description 2
- 150000002611 lead compounds Chemical class 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 230000002292 Radical scavenging effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 11
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical class OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 238000005100 correlation spectroscopy Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- BOLQJTPHPSDZHR-UHFFFAOYSA-N dihydroferulic acid Chemical compound COC1=CC(CCC(O)=O)=CC=C1O BOLQJTPHPSDZHR-UHFFFAOYSA-N 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 2
- 238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000007845 reactive nitrogen species Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000004563 wettable powder Substances 0.000 description 2
- NDAJNMAAXXIADY-UHFFFAOYSA-N 2-methylpropanimidamide Chemical compound CC(C)C(N)=N NDAJNMAAXXIADY-UHFFFAOYSA-N 0.000 description 1
- DQLKBRLDGQHWCJ-UHFFFAOYSA-N 3,4-dihydronaphthalene-2-carboxylic acid Chemical compound C1=CC=C2CCC(C(=O)O)=CC2=C1 DQLKBRLDGQHWCJ-UHFFFAOYSA-N 0.000 description 1
- LXEKPEMOWBOYRF-QDBORUFSSA-N AAPH Chemical compound Cl.Cl.NC(=N)C(C)(C)\N=N\C(C)(C)C(N)=N LXEKPEMOWBOYRF-QDBORUFSSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供了一种具有抗氧化活性的阿魏酸二聚体及其制备方法和应用。本发明的阿魏酸二聚体化合物6‑羟基‑4‑(4‑羟基‑3‑甲氧基苯基)‑7‑甲氧基‑3‑(甲氧羰基)‑3,4‑二氢萘‑2‑羧酸的结构式如式(Ⅰ)所示,其是从水稻的果实、茎或叶的干品或鲜品中分离获得。经体外药理实验证实,化合物6‑羟基‑4‑(4‑羟基‑3‑甲氧基苯基)‑7‑甲氧基‑3‑(甲氧羰基)‑3,4‑二氢萘‑2‑羧酸具有良好的超氧自由基清除能力,其PSC值为1.47±0.57μmol TE/μmol,说明其具有良好的抗氧化活性。所述的阿魏酸二聚体化合物6‑羟基‑4‑(4‑羟基‑3‑甲氧基苯基)‑7‑甲氧基‑3‑(甲氧羰基)‑3,4‑二氢萘‑2‑羧酸有望作为先导化合物开发出新型的抗氧化剂药物。
The present invention provides a ferulic acid dimer with antioxidant activity and a preparation method and application thereof. Ferulic acid dimer compound of the present invention 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydro The structural formula of naphthalene-2-carboxylic acid is shown in formula (I), which is obtained from the dried or fresh product of the fruit, stem or leaf of rice. It was confirmed by in vitro pharmacological experiments that the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2 ‑Carboxylic acid has good superoxide radical scavenging ability, and its PSC value is 1.47±0.57 μmol TE/μmol, indicating that it has good antioxidant activity. Described ferulic acid dimer compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydro Naphthalene-2-carboxylic acid is expected to be used as a lead compound to develop new antioxidant drugs.
Description
技术领域technical field
本发明属于天然药物技术领域,具体涉及一种新阿魏酸二聚体化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸及其制备方法和在制备抗氧化药物中的应用。The invention belongs to the technical field of natural medicines, in particular to a new ferulic acid dimer compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methyl) Oxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid and its preparation method and application in the preparation of antioxidant medicines.
背景技术Background technique
研究表明癌症、衰老、神经退行性疾病和心血管疾病等与过量自由基(高活性反应分子)的产生有着密不可分的联系。体内的活性氧簇(reactive oxygen species,ROS)与活性氮簇(reactive nitrogen species,RNS)的持续堆积会启动氧化应激反应(高活性反应分子产生和抗氧化作用之间长期失衡引起组织损伤),从而损害生物体的防御系统。这些活性分子可直接氧化和损伤DNA、蛋白质、脂类、激活细胞内多种与胰岛素抵抗和β-细胞功能受损相关信号通路,甚至干扰生理还原信号传导进而影响细胞增殖分化。抗氧化剂是一类具有减缓或抑制氧化作用的物质,可抑制自由基形成、清除自由基或修复受损的生物分子从而有效预防和缓解氧化应激对身体造成的损伤。具有多酚羟基结构的酚类物质如黄酮、酚酸、原花青素等表现出良好的抗氧化活性,已经成为新型抗氧化剂的重要来源。Studies have shown that cancer, aging, neurodegenerative diseases and cardiovascular diseases are inextricably linked with the production of excess free radicals (highly reactive molecules). Continued accumulation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in the body initiates oxidative stress (a long-term imbalance between the production of highly reactive molecules and their anti-oxidative effects leading to tissue damage) , thereby impairing the defense system of the organism. These active molecules can directly oxidize and damage DNA, proteins, lipids, activate a variety of intracellular signaling pathways related to insulin resistance and impaired β-cell function, and even interfere with physiological reduction signaling to affect cell proliferation and differentiation. Antioxidants are a class of substances that slow down or inhibit oxidation, which can inhibit the formation of free radicals, scavenge free radicals or repair damaged biomolecules, thereby effectively preventing and alleviating the damage caused by oxidative stress to the body. Phenolic substances with polyphenolic hydroxyl structures, such as flavonoids, phenolic acids, and proanthocyanidins, exhibit good antioxidant activity and have become an important source of new antioxidants.
水稻(Citrusgrandis L.Osbeck)是禾本科稻属植物,其果实是世界上近一半人口的主食,前人报道水稻中含有丰富的酚类物质,且有相当部分的酚类以结合态的形式存在,这些酚类物质有望成为新型的天然抗氧化剂。目前未见有水稻中具有抗氧化活性的6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸成分的研究报道。Rice (Citrusgrandis L.Osbeck) is a genus of Poaceae, and its fruit is the staple food of nearly half of the world's population. It has been reported that rice is rich in phenolics, and a considerable part of phenolics exists in the form of binding. , these phenolic substances are expected to become new natural antioxidants. 6-Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-diol with antioxidant activity in rice has not been found so far. Research report on the composition of hydronaphthalene-2-carboxylic acid.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种新的阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸,并提供其制备方法,以及提供其在制备具有抗氧化作用的药物中的应用。The purpose of the present invention is to provide a new ferulic acid dimer component 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl) -3,4-dihydronaphthalene-2-carboxylic acid, and a preparation method thereof, and application of the same in the preparation of medicines with antioxidative effect.
本发明所述的新阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸,或其药用盐,或其酯化衍生物,其结构如式(Ⅰ)表示:The novel ferulic acid dimer component of the present invention is 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4 -Dihydronaphthalene-2-carboxylic acid, or a pharmaceutically acceptable salt thereof, or an esterified derivative thereof, the structure of which is represented by formula (I):
本发明所述的新阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸由本发明人首次从水稻(Oryza sativa L.)各个组织部位的干品或鲜品中分离获得,具体部位可以是糙米、糠层和精米层。The novel ferulic acid dimer component of the present invention is 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4 -Dihydronaphthalene-2-carboxylic acid was isolated and obtained by the inventors for the first time from dried or fresh products of various tissue parts of rice (Oryza sativa L.), and the specific parts can be brown rice, bran layer and polished rice layer.
本发明提供的新阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸,经体外药理实验证实,具有良好的超氧自由基(PSC)清除能力,其PSC值为1.47±0.57μmol TE/μmol。所述的新阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸、或其药用盐、或其酯化衍生物可用于制备抗氧化药物。The novel ferulic acid dimer component provided by the present invention is 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4- Dihydronaphthalene-2-carboxylic acid was confirmed by in vitro pharmacological experiments to have good superoxide radical (PSC) scavenging ability, and its PSC value was 1.47±0.57μmol TE/μmol. The new ferulic acid dimer component 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-di Hydronaphthalene-2-carboxylic acid, or a pharmaceutically acceptable salt thereof, or an esterified derivative thereof can be used to prepare antioxidant drugs.
本发明的新阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸、或其药用盐、或其酯化衍生物可与制剂或药物允许的赋形剂或载体结合,制备得到具有抗氧化活性的可用于缓解氧化应激的药物或药物组合物。该药物或药物组合物可以采用可湿性粉剂、片剂、颗粒剂、胶囊、口服液、滴丸、注射剂、气雾剂等剂型;还可采用现代制药界所公知的控释或缓释剂型或纳米制剂。The novel ferulic acid dimer component of the present invention 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-di Hydronaphthalene-2-carboxylic acid, or its pharmaceutically acceptable salt, or its esterified derivative can be combined with a preparation or a pharmaceutically acceptable excipient or carrier to prepare a drug with antioxidant activity that can be used to relieve oxidative stress or pharmaceutical composition. The medicine or pharmaceutical composition can be in wettable powder, tablet, granule, capsule, oral liquid, drop pill, injection, aerosol and other dosage forms; it can also adopt controlled-release or sustained-release dosage forms known in the modern pharmaceutical industry or Nanoformulations.
因此,本发明还提供了一种抗氧化药物,其包括上述新阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸、或其药用盐,或其酯化衍生物,作为活性成分。Therefore, the present invention also provides an antioxidant drug, which comprises the above-mentioned new ferulic acid dimer component 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy- 3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid, or a pharmaceutically acceptable salt thereof, or an esterified derivative thereof, as an active ingredient.
所述的抗氧化药物还包括制剂或药物允许的赋形剂或载体,如可以采用可湿性粉剂、片剂、颗粒剂、胶囊、口服液、滴丸、注射剂、气雾剂等剂型;还可采用现代制药界所公知的控释或缓释剂型或纳米制剂。The antioxidant drug also includes formulations or pharmaceutically acceptable excipients or carriers, such as wettable powder, tablet, granule, capsule, oral liquid, drop pill, injection, aerosol and other dosage forms; The controlled-release or sustained-release dosage forms or nano-formulations well known in the modern pharmaceutical industry are used.
本发明还提供了新阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的制备方法,其是从水稻(Oryza sativa L.)植物中分离获得,包括水稻的果实、茎或叶的干品或鲜品。优选,是从水稻果实各个组织部位的干品或鲜品中分离获得,具体部位可以是糙米、糠层和/或精米。The present invention also provides a new ferulic acid dimer component 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4 -The preparation method of dihydronaphthalene-2-carboxylic acid, which is obtained from rice (Oryza sativa L.) plants, including dried or fresh products of fruit, stem or leaf of rice. Preferably, it is obtained from dry or fresh products of various tissue parts of rice fruit, and the specific parts can be brown rice, bran layer and/or polished rice.
本发明的新阿魏酸二聚体成分6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的制备方法,具体步骤优选为:将水稻粉碎后用乙醇水溶液浸提,分离提取液收集残渣,提取残渣加入NaOH溶液后氮气环境下提取,随后调节pH至1,用乙酸乙酯萃取,收集乙酸乙酯相减压浓缩去除有机溶剂后得到提取物,提取物经正相硅胶柱层析,用氯仿/甲醇从体积比100:0至60:40梯度洗脱,收集氯仿/甲醇体积比90:10洗脱的组分F2,组分F2采用ODS-A中压柱层析,用甲醇/水醇从体积比30:70至90:10梯度洗脱,收集甲醇/水体积比70:30洗脱的组分F2-8,流份F2-8经高效液相分离纯化得到6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸。The novel ferulic acid dimer component of the present invention 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-di The preparation method of hydronaphthalene-2-carboxylic acid, the specific steps are preferably as follows: the rice is pulverized and then leached with an ethanol aqueous solution, the extract is separated and the residue is collected, the extraction residue is added to a NaOH solution and extracted under a nitrogen environment, and then the pH is adjusted to 1, and the Extract with ethyl acetate, collect the ethyl acetate phase and concentrate under reduced pressure to remove the organic solvent to obtain the extract. The extract is subjected to normal phase silica gel column chromatography, eluted with a gradient of chloroform/methanol from 100:0 to 60:40 by volume, and collected. Component F2 eluted with a volume ratio of chloroform/methanol of 90:10. Component F2 was chromatographed on an ODS-A medium pressure column, eluted with a gradient of methanol/water alcohol from a volume ratio of 30:70 to 90:10, and collected methanol/water. Fraction F2-8 eluted with a water volume ratio of 70:30, fraction F2-8 was purified by high performance liquid phase separation to obtain 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methyl Oxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid.
本发明采用水稻果实组织中提取分离高效抗氧化剂剂(药物)-阿魏酸二聚体化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸,其制备过程条件可控,提取方便,对环境友好并有潜在好的经济效益,且得到的新阿魏酸二聚体化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸性质稳定、易存放。其抗氧化活性良好,有望作为先导化合物开发出新型的抗氧化药物。The invention adopts the extraction and separation of high-efficiency antioxidant (drug)-ferulic acid dimer compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy- 3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid has controllable preparation process conditions, convenient extraction, environmental friendliness and potential good economic benefits, and the obtained new dihydroferulic acid Polymer Compound 6-Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid Properties Stable and easy to store. It has good antioxidant activity and is expected to be used as a lead compound to develop new antioxidant drugs.
附图说明Description of drawings
图1是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的1H NMR图谱;Figure 1 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid 1 H NMR spectrum of ;
图2是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的13C NMR图谱;Figure 2 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid The 13 C NMR spectrum of ;
图3是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的1H-1H COSY图谱;Figure 3 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid 1 H -1 H COSY spectrum of ;
图4是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的HSQC图谱;Figure 4 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid The HSQC spectrum of ;
图5是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的HMBC图谱;Figure 5 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid HMBC spectrum of ;
图6是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的HR-EI-MS图谱。Figure 6 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid HR-EI-MS spectrum.
具体实施方式Detailed ways
以下实施例是对本发明的进一步说明,不是对本发明的限制,根据本发明的实质对本发明进行的简单改进都属于本发明要求保护的范围。The following examples are further descriptions of the present invention, not limitations of the present invention. Simple improvements to the present invention according to the essence of the present invention all belong to the scope of protection of the present invention.
实施例1:阿魏酸二聚体化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的制备Example 1: Ferulic acid dimer compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-di Preparation of Hydronaphthalene-2-Carboxylic Acid
1.1植物来源与鉴定1.1 Plant origin and identification
供提取用植物材料水稻(Oryza sativa L.)的果实样品购自黑龙江省哈尔滨市。Fruit samples of rice (Oryza sativa L.), a plant material for extraction, were purchased from Harbin, Heilongjiang Province.
1.2提取与分离1.2 Extraction and separation
将水稻果实(稻谷)粉碎后用体积分数95%的乙醇水溶液浸提48小时,分离提取液收集残渣,提取残渣加入2M的NaOH溶液(1:20,w/v g/ml)后氮气环境下提取4小时,随后用6M HCl调节pH至1,用乙酸乙酯萃取(1:1,v/v)5次,收集乙酸乙酯相减压浓缩去除有机溶剂后得到提取物。提取物经正相硅胶柱层析,用氯仿/甲醇从体积比100:0至60:40梯度洗脱,收集氯仿/甲醇体积比90:10洗脱的组分F2,组分F2采用ODS-A中压柱层析,用甲醇/水醇从体积比30:70至90:10梯度洗脱,收集甲醇/水体积比70:30洗脱的组分F2-8,亚组分F2-8以45%甲醇水溶液(v/v)为流动相,以6mL/min为流速,通过制备HPLC采用Shim-pack PRC-ODSC-18柱(5μm,20×250mm)进一步层析分离纯化得化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸(3mg,tR 128min)。The rice fruit (rice) was crushed and extracted with 95% ethanol aqueous solution for 48 hours. The extract was separated and the residue was collected. The extraction residue was added with 2M NaOH solution (1:20, w/v g/ml) and extracted under nitrogen atmosphere. After 4 hours, the pH was adjusted to 1 with 6M HCl, extracted with ethyl acetate (1:1, v/v) for 5 times, and the ethyl acetate phase was collected and concentrated under reduced pressure to remove the organic solvent to obtain an extract. The extract was subjected to normal-phase silica gel column chromatography, eluted with a gradient of chloroform/methanol from 100:0 to 60:40 in a volume ratio, and the fraction F2 eluted with a chloroform/methanol volume ratio of 90:10 was collected. A medium pressure column chromatography, gradient elution with methanol/water alcohol from 30:70 to 90:10 by volume, fraction F2-8 and subfraction F2-8 eluted with methanol/water volume ratio of 70:30 were collected Using 45% methanol aqueous solution (v/v) as the mobile phase and 6 mL/min as the flow rate, the compound 6- Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid (3 mg, tR 128 min) .
1.3新阿魏酸二聚体化合物的结构鉴定1.3 Structural identification of new ferulic acid dimer compounds
图1是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的1H NMR图谱;图2是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的13C NMR图谱;图3是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的1H-1H COSY图谱;图4是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的HSQC图谱;图5是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的HMBC图谱;图6是化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的HR-EI-MS图谱;6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸,淡黄色油状物;UV(MeOH)λmax nm(logε)225(4.34),289(3.89),326(3.87);HRESIMS m/z 401.1250[M+H]+(calcd for C21H21O8+,401.1231,error-1.9mDa)and 423.1070[M+Na]+(calcd for C21H20NaO8+423.1050,error-2.0mDa);1H(500MHz)and 13C(125MHz)核磁数据陈列如下表1所示。Figure 1 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid 1 H NMR spectrum of ; Figure 2 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydro 13 C NMR spectrum of naphthalene-2-carboxylic acid; Figure 3 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)- 1 H- 1 H COSY spectrum of 3,4-dihydronaphthalene-2-carboxylic acid; Figure 4 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy The HSQC spectrum of -3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid; Figure 5 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7 - HMBC spectrum of -methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid; Figure 6 is the compound 6-hydroxy-4-(4-hydroxy-3-methoxybenzene yl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid HR-EI-MS spectrum; 6-hydroxy-4-(4-hydroxy-3- Methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid, pale yellow oil; UV(MeOH)λmax nm(logε)225( 4.34), 289(3.89), 326(3.87); HRESIMS m/z 401.1250[M+H] + (calcd for C21H21O8 + , 401.1231, error-1.9mDa) and 423.1070[M+Na] + (calcd for C21H20NaO8+ 423.1050, error-2.0mDa); 1 H (500MHz) and 13 C (125MHz) NMR data are shown in Table 1 below.
表1.化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的NMR数据(in CD3OD)Table 1. Compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid NMR data (in CD 3 OD)
根据以上紫外、质谱和一维和二维核磁等波谱相关数据的综合分析,解析推导出化合物的结构式如式(Ⅰ)所示,命名为6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸:According to the comprehensive analysis of the above UV, mass spectrometry and one-dimensional and two-dimensional nuclear magnetic resonance data, the structural formula of the compound is analytically deduced as shown in formula (I), named 6-hydroxy-4-(4-hydroxy-3-methoxy phenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid:
实施例2:阿魏酸二聚体化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的抗氧化活性检测Example 2: Ferulic acid dimer compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-di Antioxidant activity detection of hydronaphthalene-2-carboxylic acid
1.仪器与材料1. Instruments and materials
二甲基亚砜为美国剑桥公司生产;Trolox试剂、荧光素,2,2'-偶氮(2-甲基丙脒)盐酸盐(AAPH)购自于美国Sigma公司;酶标仪为Genois microplate reader(TecanGENios,Swizerland)。Dimethyl sulfoxide was produced by Cambridge Company, USA; Trolox reagent, fluorescein, 2,2'-azo(2-methylpropionamidine) hydrochloride (AAPH) were purchased from Sigma Company, USA; microplate reader was Genois microplate reader (TecanGENios, Swizerland).
2.PSC活性评价2. Evaluation of PSC activity
采用荧光酶标仪检测法测定化合物的PSC抗氧化能力。Trolox标准品及各种待测样品用75mM磷酸缓冲液(PH=7.4)溶解稀释到适当的浓度,80μL浓度为2.48mM的DCFH-DA加入900μL 1.0mM KOH水解5分钟,去除二乙酸酯(DA)部分,得到活化的DCFH溶液。将100μL纯化合物或提取物(在75mM磷酸盐缓冲液(pH 7.4)中适当稀释)转移到96孔板中,并添加100μL DCFH。将96孔板装入荧光分光光度计板架中,通过以1200rpm的转速振荡20s来混匀每个孔中的溶液,然后再加50μL 200mM ABAP来启动反应。反应在37℃下进行,用荧光分光光度计在485nm激发和538nm发射下监测荧光,每2min测一次,持续40min。Trolox(维生素E)作为阳性对照。每个试验3个重复,根据Trolox标准曲线计算测试样品的PSC值,结果以Trolox当量进行表示(μmol TE/μmol)。The PSC antioxidant capacity of the compounds was determined by fluorescence microplate reader assay. Trolox standard and various samples to be tested were dissolved and diluted to the appropriate concentration with 75mM phosphate buffer (PH=7.4), 80μL of DCFH-DA with a concentration of 2.48mM was added to 900μL of 1.0mM KOH and hydrolyzed for 5 minutes to remove diacetate ( DA) part to obtain an activated DCFH solution. 100 μL of pure compound or extract (appropriately diluted in 75 mM phosphate buffer (pH 7.4)) was transferred to a 96-well plate and 100 μL of DCFH was added. The 96-well plate was loaded into a spectrofluorometer plate holder and the reaction was started by mixing the solution in each well by shaking at 1200 rpm for 20 s, followed by an additional 50 μL of 200 mM ABAP. The reaction was carried out at 37°C, and the fluorescence was monitored with a spectrofluorometer at 485 nm excitation and 538 nm emission, every 2 min for 40 min. Trolox (vitamin E) served as a positive control. Each experiment was replicated three times, and the PSC values of the test samples were calculated according to the Trolox standard curve, and the results were expressed in Trolox equivalents (μmol TE/μmol).
PSC(unit)=1-(SA/CA)PSC(unit)=1-(SA/CA)
式中,SA是样品或标准品的AUC,CA是仅使用缓冲液的对照反应的AUC。where SA is the AUC of the sample or standard and CA is the AUC of the buffer only control reaction.
3.实验数据参见表2:3. The experimental data are shown in Table 2:
表2.化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸的抗氧化活性Table 2. Compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-dihydronaphthalene-2-carboxylic acid antioxidant activity
4.实验结论:4. Experimental conclusion:
本实验表明,阿魏酸二聚体化合物6-羟基-4-(4-羟基-3-甲氧基苯基)-7-甲氧基-3-(甲氧羰基)-3,4-二氢萘-2-羧酸具有良好的抗氧化活性,将可望能被开发用于制备抗氧化药物,应用潜质广泛,前景看好。This experiment shows that the ferulic acid dimer compound 6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)-3,4-di Hydronaphthalene-2-carboxylic acid has good antioxidant activity, and it is expected to be developed for the preparation of antioxidant drugs, with wide application potential and promising prospects.
以上仅是本发明的优选实施方式,应当指出的是,上述优选实施方式不应视为对本发明的限制,本发明的保护范围应当以权利要求所限定的范围为准。对于本技术领域的普通技术人员来说,在不脱离本发明的精神和范围内,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention. It should be noted that the above preferred embodiments should not be regarded as limitations of the present invention, and the protection scope of the present invention should be based on the scope defined by the claims. For those skilled in the art, without departing from the spirit and scope of the present invention, several improvements and modifications can also be made, and these improvements and modifications should also be regarded as the protection scope of the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110250452.5A CN113121353B (en) | 2021-03-08 | 2021-03-08 | Ferulic acid dimer with antioxidant activity and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110250452.5A CN113121353B (en) | 2021-03-08 | 2021-03-08 | Ferulic acid dimer with antioxidant activity and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113121353A CN113121353A (en) | 2021-07-16 |
CN113121353B true CN113121353B (en) | 2022-04-26 |
Family
ID=76773159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110250452.5A Active CN113121353B (en) | 2021-03-08 | 2021-03-08 | Ferulic acid dimer with antioxidant activity and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113121353B (en) |
-
2021
- 2021-03-08 CN CN202110250452.5A patent/CN113121353B/en active Active
Non-Patent Citations (2)
Title |
---|
"阿魏酸二聚体的抗氧化性及其选择性合成的研究";贾媛;《中国优秀硕士学位论文全文数据库,工程科技II辑》;20200215(第02期);第C041-19页,正文第15-30页 * |
RN 1195154-49-4;STN;《STN-REG》;20091202;第1页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113121353A (en) | 2021-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4941991B2 (en) | Proanthocyanidin oligomer production method | |
CA2554182A1 (en) | Compositions enriched in phenolic compounds and methods for producing the same | |
CN107698546B (en) | Compound Oleracone D and its extraction separation method in purslane | |
CN107746397B (en) | Compound Oleracone C and its extraction separation method in purslane | |
CN108558809A (en) | Compound Oleracone F and its extraction separation method in purslane | |
CN113121353B (en) | Ferulic acid dimer with antioxidant activity and preparation method and application thereof | |
CN101591325B (en) | A kind of method of extracting catechin | |
CN111410643B (en) | Preparation and application of a new cinnamoyl catechin and four new phenylpropanoid flavan alkaloids | |
CN103232427B (en) | Xanthone compound as well as preparation method and application thereof | |
CN111253247B (en) | Preparation method and application of novel phenolic acid compound with anti-inflammatory activity | |
CN116606286B (en) | Furan alkaloid in purslane and extraction and separation method thereof | |
CN103739653B (en) | A kind of 23-fall oleanane acid compound and preparation method thereof and the purposes in preparing glycosidase inhibitor | |
CN103027909B (en) | Application of coumarins compounds and method for extracting coumarins compounds from winter daphne | |
CN107540686B (en) | A kind of coumarin compound containing benzofuran ring, preparation method and application thereof | |
CN113105418B (en) | A kind of phenolic acid with cellular antioxidant activity and preparation method and application thereof | |
CN113087752B (en) | A kind of flavonoid glycoside with antioxidant activity and preparation method and application thereof | |
CN103613632B (en) | 29-noroleananoic acid compound and its preparation method and application in the preparation of glycosidase inhibitor medicine | |
CN103301102B (en) | A kind of method and application of extracting anti-oxidant from Shuibai branch | |
CN110734449B (en) | Pterostilbene compounds in fenugreek, preparation method and application thereof | |
CN107382728B (en) | 2- (3, 4-dihydroxyphenyl) ethanol succinic acid diester and extraction method and application thereof | |
CN114656393B (en) | A kind of pyrrole-2-aldehyde compound and its preparation method and application | |
KR100542323B1 (en) | Method for isolating compounds having induction of apoptosis from hawthorn tree | |
CN116082145B (en) | Fibrate derivative with antioxidant activity, synthesis method and application thereof | |
CN111559962B (en) | Preparation method and application of novel phenolic acid compound with antioxidant activity | |
CN101298450B (en) | Extraction and separation method of brevifolia hematoxylin and 8,9-monoepoxy brevifolia hematoxylin active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20210716 Assignee: NPGS (GUANGDONG) BIOTECHNOLOGY CO.,LTD. Assignor: SERICULTURE & AGRI FOOD Research Institute GAAS Contract record no.: X2022980012718 Denomination of invention: A kind of ferulic acid dimer with antioxidant activity and its preparation method and application Granted publication date: 20220426 License type: Common License Record date: 20220818 |